We show that the allele-dependent expression of transcripts encoding soluble HLA-DQb chains is determined by branchpoint sequence (BPS) haplotypes in DQB1 intron 3. BPS RNAs associated with low inclusion of the transmembrane exon in mature transcripts showed impaired binding to splicing factor 1 (SF1), indicating that alternative splicing of DQB1 is controlled by differential BPS recognition early during spliceosome assembly. We also demonstrate that naturally occurring human BPS point mutations that alter splicing and lead to recognizable phenotypes cluster in BP and in position 22 relative to BP, implicating impaired SF1 -BPS interactions in disease-associated BPS substitutions. Coding DNA variants produced smaller fluctuations of exon inclusion levels than random exonic substitutions, consistent with a selection against coding mutations that alter their own exonization. Finally, proximal splicing in this multi-allelic reporter system was promoted by at least seven SR proteins and repressed by hnRNPs F, H and I, supporting an extensive antagonism of factors balancing the splice site selection. These results provide the molecular basis for the haplotype-specific expression of soluble DQb, improve prediction of intronic point mutations and indicate how extraordinary, selection-driven DNA variability in HLA affects pre-mRNA splicing.
INTRODUCTION
Alternative pre-mRNA splicing (AS), or a generation of multiple transcripts from a single pre-mRNA, is a fundamental mechanism of regulating gene expression and generating proteomic diversity (1) . The estimated frequency of human genes that undergo AS has risen dramatically from 5% to well over 50% in the last decade (2) , but the proportion of the AS events that have functional consequences is currently unknown (3) .
The recognition of splice sites involves cross-talk between multiple interactions that contribute to complexes that commit the pre-mRNA to splicing. The splicing reaction occurs in the spliceosome, which consists of the pre-mRNA substrate, four small nuclear ribonucleoprotein particles (snRNPs U1, U2, U4/U6 and U5) and a large number of proteins (4) . In higher eukaryotes, the requirement for accurate splicing is accompanied by weakly conserved consensus sequences: the 5 0 splice sites, 3 0 splice site, polypyrimidine tract (PPT) and branch point sequence (BPS). These elements are necessary but often insufficient to define exon-intron boundaries. Auxiliary cis-elements that activate or repress splicing, known as exonic and intronic splicing enhancers or silencers (ESEs, ISEs and ESSs, ISSs), allow the genuine splice sites to be correctly recognized among pseudo-splice sites with similar signal sequences. These cis-elements have been identified through mutations that alter splicing, through computational comparisons and through the selection of sequences that activate splicing or bind to splicing regulatory proteins, most notably a family of serine-arginine (SR) proteins (5) (6) (7) (8) (9) . Disease-causing mutations that affect splicing have contributed to our understanding of splicing signal sequences; however, the influence upon splicing of naturally occurring DNA polymorphisms has not been systematically studied.
Genes encoding histocompatibility leukocyte antigens (HLA) are among the most polymorphic loci in the human genome. A high, selection-driven DNA variability of both class I and class II genes is instrumental for the development of adaptive immune responses; the absent or diminished expression of the latter, results in immunodeficiency (reviewed in 10). Although the HLA genes are the most important genetic risk factors for the development of a large number of autoimmune disorders, including multiple sclerosis, rheumatoid arthritis, juvenile diabetes and narcolepsy, it is not known how their AS is controlled.
Alternatively spliced HLA isoforms that lack exons encoding the transmembrane domains enter the endocytic compartment, are released by cells and can be detected as soluble molecules (sHLA) in body fluids (11, 12) . sHLAs have been shown to induce apoptosis of alloreactive cells in vitro and modulate immune responses (13, 14) . Their serum levels are increased in inflammatory and autoimmune diseases and correlate positively with disease activity and autoantibody titres (12) . In addition, sHLA levels in normal individuals have been linked to HLA haplotypes, with the highest sHLA class II concentration in individuals carrying DR3 and DR4 alleles (15) , but mechanisms underlying their haplotype-dependent expression have not been elucidated.
HLA-DQB1 shows variable inclusion of two exons in mature transcripts. Exon 5, which encodes the cytoplasmic portion of DQb, is incorporated into mRNA only on alleles that have a IVS4-1A!G substitution at the splice acceptor site. Although both alternatively spliced isoforms restrict antigens, transfectants lacking exon 5 were somewhat less efficient at comparable expression levels than those containing this exon (16) . Exon 4, which codes for the transmembrane domain of DQb, is differentially included in mRNA in cell lines carrying particular homozygous DQB1 genotypes (11) , but the molecular mechanism for the allele-dependent production of sDQb chains is not understood.
Here we show that BPS and PPT variants in intron 3 are major determinants of the allele-specific production of DQB1 transcripts lacking exon 4 (D4). Relative levels of DQB1 isoforms were markedly influenced by two single nucleotide polymorphisms (SNPs) in BPS, implicating naturally occurring BPS haplotypes in AS. Exon inclusion levels of BPS haplotypes correlated with in vitro binding of splicing factor 1 (SF1) to BPS RNAs. In addition, we also demonstrate a biased distribution of disease-causing point mutations in human BPS (hBPS) and propose that impaired SF1-BPS interactions early during spliceosome contribute to splicing defects in these cases. Moreover, we show that AS of this multi-allelic reporter is controlled by at least seven SR proteins and at least three heterogenous nuclear ribonucleoproteins (hnRNPs) and provide a mechanistic explanation for their opposite effects on splice site selection. Finally, we show how subphysiological temperatures alter the allelespecific expression of DQB1 isoforms and propose that the observed changes in exon inclusion may account for temperature-sensitive course of autoimmune disorders associated with high D4.
RESULTS

Identification of cis-acting elements that control differential exon 4 inclusion
To determine factors responsible for the allele-specific production of D4, we first characterized DQB1 exon 4 splicing in a panel of lymphoblastoid cell lines homozygous at DQB1. We confirmed the absence of D4 in cell lines carrying DQB1 Ã 02 and Ã 05 alleles (Fig. 1A ) that do not secrete sDQb (11) . We next constructed minigenes derived from D4-producing and non-producing lineages (Fig. 1B) and determined exon inclusion levels after transient transfection of the wild-type constructs into HeLa and 293T cells (Fig. 1C) . The allele-specific minigenes retained the signals required for differential exon inclusion in both cell types, indicating that D4 variability is determined by polymorphisms within the constructs. To define these cis-elements, we sequenced flanking introns in homozygous cell lines carrying 10 DQB1 alleles that are common in the population. We found -PCR was with upper (T31-32, T37, T41) and lower (T28-29, T40) haplotype-specific primers. Exon inclusion (EI) levels were measured from duplicate cultures. DQB1 exons 3, 4 and 6 are shown as white, grey and black boxes, respectively. (B) Allele-specific minigenes. Exons (boxes, E) and introns (lines) are to scale; scale units are kilobases (kb). All primers (arrows) are shown in Supplementary Material, Table S1 . An open rectangle at the 3 0 splice site of intron 3 indicates a multiple sequence alignment shown in Fig. 2A . (C) Transient D4 levels following transfection of wildtype minigenes into HEK293T and HeLa cells. Amplification was with vector primers PL3 and PL4. Mean and SD were derived from three duplicate transfections. (D) The nucleotide diversity (P (i ) , 93) in DQB1 intron 3. Nucleotide sequences of introns 3-5 are available from Genbank (Accession nos AY553273-AY553292).
a total of 65 polymorphisms in intron 3 and 112 polymorphisms in intron 4/5, excluding the sites with alignment gaps. The nucleotide variability was notably higher in the 3 0 part of the intron than in the 5 0 part (Fig. 1D) , suggesting intron homogenization in the region adjacent to b2-encoding exon 3.
To identify SNPs that determine differential splicing, a minigene producing a mixture of exon inclusion and skipping ( Ã 0602 ) was individually mutated in eight exonic and 10 flanking intronic SNPs revealed by multiple sequence alignments ( Fig. 2A and B) . IVS3-24A!T and IVS3-6C!T mutations strikingly reduced D4, whereas the remaining intronic SNPs, including those close to the 3 0 (Fig. 2B ) and 5 0 (IVS4þ14A/G, IVS4þ33G/C, data not shown) splice sites, resulted in minor or no D4 alterations. Mutations in most exonic SNPs altered D4 levels, but to a smaller extent than IVS3-24 or IVS3-6 (Fig. 2C) . To confirm the importance of SNPs that influence D4, we introduced mutations in the same positions into a minigene that contained IVS3-24T/-6T and produced virtually no D4 ( Ã 050101). Measurement of low D4 levels with a sensitive real-time RT-PCR assay (Supplementary Material, Fig. S1 ) showed that maximum exon skipping was conferred by IVS3-24T!A followed by IVS3-6T!C (Fig. 2D ). In addition, IVS-26A!G substantially reduced exon 4 inclusion of both Ã 0602 and Ã 050101 minigenes ( Fig. 2B and D) , indicating that IVS3-26, -24 and -6 were key SNPs responsible for differential splicing of both DQB1 alleles.
Exon 4 inclusion is determined by BPS haplotypes
The SNPs IVS3-24 and -26 were within the best match to the hBPS consensus (YNYURAY) near the 3 0 splice site ( Fig. 2A) . A pre-mRNA substrate consisting of DQB1 exons 3 and 4 and complete intron 3 was spliced in vitro (Fig. 3A) and the BP was mapped by reverse transcription across the 5 0 -2 0 bond of the BP, followed by inverse PCR (17) and sequencing (Fig. 3B) . The identification of A-22 as the BP was further supported by complete exon skipping caused by mutation 222A!G and deletion IVS3D-21 -27, whereas the replacement of the same heptamer with the yeast consensus UACUAAC (yBPS), which is the preferred mammalian BPS (18) , dramatically improved exon inclusion (Fig. 2B) . Together, these results indicated that IVS3-21 -27, which contains two SNPs, is the BPS of exon 4.
Next, we systematically examined how each of the six BPS haplotypes controls exon inclusion (Fig. 3C) (Fig. 3C ). We therefore sequenced BPS of additional DQB1 alleles associated with IVS3-26G or -24A/C. Without exception, homozygous cell lines carrying IVS3-26G and -24A/-24C had -24T and -26A, respectively ( Fig. 2A ). In addition, genotyping of over 1600 Caucasian chromosomes using a haplotype-specific ( Fig. 3D ) amplification refractory mutation system (ARMS) -PCR (19) did not reveal these haplotypes. These observations prompt the hypothesis that these intronic sequences may have been subject to negative selection through diminished expression of natural transcripts, leading to immunodeficiency and predisposition to infections.
Impaired interactions of SF1 with BPS RNAs that produce high D4
During spliceosome assembly the BPS is recognized first by splicing factor 1 (SF1; branchpoint binding protein) in the early (E) complex (20, 21) , and later by base-pairing with U2 snRNA in the A complex (22 -24) . The influence of BPS haplotypes on exon 4 splicing could be mediated by the interactions of either or both of these trans-acting factors with the BPS. To test if SF1 binding to BPS haplotypes correlates with exon inclusion, we examined the interaction between small synthetic BPS-containing RNAs with wild-type and mutated Next, we tested if U2 snRNA -BPS base-pairing can alter exon inclusion. We cotransfected DQB1 Ã 0602 reporters with plasmids expressing U2 snRNA and carrying complementary mutations in the BPS-interacting region. Surprisingly, despite high expression of mutated U2 snRNA (Fig. 4C ) and repeated experiments with several vectors, we observed no significant decrease of transient D4 (Fig. 4D) .
Predominance of hBPS point mutations in BP and BP-2
Comparison of previously published disease-associated singlebase substitutions in hBPS showed that these alterations occurred only in BP and BP-2 (Table 1) . Their biased distribution across BPS ( p ¼ 10
26
, binomial test for both BP and BP-2) suggests that point mutations in the remaining BPS positions give rise to no or only minor splicing defects and do not produce recognizable phenotypes. Since BP-2U mutations markedly impair SF1 -BPS interactions (Fig. 4A) (20, 25) and BPSs in naturally occurring BP-2U substitutions (Table 1) were similar to those in DQB1 IVS3 ( Fig. 2A) , the associated splicing abnormalities of hBP-2 mutations are likely to arise through weakened SF1 binding. Because BP mutations efficiently reduce these interactions as well (20, 25) , the majority, if not all, single nucleotide substitutions in hBPS may affect splicing via impaired SF1 -BPS binding.
A predominance of A!G transitions in BP (Table 1 ) suggested that hBP mutated to pyrimidines, which can be used for productive lariat formation (26) , generate more natural transcripts than BP-A!G transitions, consistent with a more severe reduction of the first and second splicing steps in vitro observed for guanine-containing substrates (27) . To test this in vivo, we examined DQB1 isoforms after transfection of the Ã 0602 minigenes mutated at BP into 293T cells. The transition mutant (BP-A!G) gave the highest expression of transient D4, whereas both transversions yielded lower amounts (Fig. 4E) . However, because BP transversions and transitions in very short introns may generate similar levels of exon skipping (28) , their phenotypic outcome is likely to be influenced by intronic sequences. This is further supported by comparison of the splicing phenotype of human BPS alterations with intronic length, suggesting that mutations in very short introns, particularly those in BP-2, tend to result in intron retention, whereas those in longer introns usually skip downstream exons (Table 1) .
Phenotypic consequences of BPS substitutions are influenced by the intronic context
To further test these predictions, we examined minigenes with truncated introns (Fig. 5A ). When compared with the wildtype minigene, the truncated Ã 0602 minigene showed negligible exon 4 skipping and substantial intron 3 retention (Fig. 5A, lane 2) . In contrast, a chimeric construct, in which exon 4 and flanking intronic sequences were derived from the D4-lacking allele ( Ã 050101, Fig. 1C ), produced transcripts that retained only minimal amounts of intron 3 (Fig. 5A, lane 1) . Since the two minigenes diverged in only four SNPs, we mutated each position in the former construct and examined the splicing pattern. IVS3-24A!T showed the most prominent reduction of intron 3 inclusion, whereas mutations in the (110) 106 (111) 238 Human
remaining SNPs contributed much less to retention (Fig. 5A) , further supporting the importance of BP-2 uracil in intron 3 removal and exon 4 skipping. Diverse splicing and clinical outcome of BP-2T substitutions is thus determined by intronic sequences, most likely involving intron -bridging interactions mediated by SF1, consistent with the central role of this protein in yeast cross-intron contacts (29) and with the retention of short (30, 31) , but not long introns (Fig. 1A and C) (32) in disease-causing BP-2T substitutions.
Opposite effects of SR proteins and hnRNPs on DQB1 splicing
To examine the influence of protein factors known to regulate splicing on both exon 4 inclusion and intron 3 retention, we individually cotransfected DQB1 reporters with plasmids expressing SR proteins, a subset of hnRNPs and several members of the CUG-BP and ETR-3 like factor (CELF) protein family. Surprisingly, transcripts retaining intron 3 were 
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increased in cells overexpressing SR proteins in both the truncated (Fig. 5B ) and the full-length (data not shown) minigenes. In contrast, transcripts that retained intron 3 were diminished in cells overexpressing hnRNP I (polypyrimidine binding protein, PTB), F and H. The splicing pattern induced by alternatively spliced PTB isoforms was similar, except for PTB-T, which lacks exons 3-10 and RNA recognition motifs (RRM) 1 and 2 (33) . Among constructs with serial deletions of 100 bp segments in intron 3 (Fig. 5A) , deletion of segment 3 generated maximum ASF/SF2-induced intron retention (Fig. 5C ). This segment was predicted to form significant RNA secondary structure, but multiple substitutions designed to remove the most prominent stem-loop (Fig. 5D ) had no effect on intron retention or exon skipping both in the wildtype and shortened Ã 0602 minigenes (data not shown). Figure 5E shows DQB1 transcripts after cotransfection of the wild-type and truncated reporters with plasmids expressing ASF/SF2 and PTB. Truncations in either intron markedly elevated levels of intron 3-retaining transcripts. In contrast, exon skipping was promoted by removal of intron 3 sequences, but was eliminated by truncation of the second intron. The opposite effects of ASF/SF2 and PTB were dose-dependent and cotransfection of a constant PTB amount with increasing amounts of ASF/SF2 and vice versa antagonized the effects of either protein (data not shown). Importantly, ASF/SF2 lacking RRM1 or RRM2 lost the intron-retaining activity (Fig. 5E ). The absence of RRM2, but not RRM1, promoted exon skipping of reporters truncated in intron 4/5. Interestingly, a lack of RS domain did not eliminate repression of intron 3 splicing, but enhanced retention of intron 4/5. RNA binding was thus essential for the PTB-mediated activation and the ASF/ SF2-induced repression of intron 3 splicing, whereas the RS domain was dispensable for the ASF/SF2-mediated retention of weakly spliced intron 3, but not strong intron 4/5.
Exon 4 inclusion is controlled by ESE 5D
Most constructs mutated in exon 4 SNPs reproducibly increased (E4þ74, E4þ98, Eþ106) or reduced (E4þ89, E4þ42, E4þ80, Eþ94) exon inclusion. Because D4 expression was most influenced by E4þ74 (Fig. 2C) , we examined this SNP in more detail. A functional SELEX tool (34) that may facilitate identification of ESEs responsive to a subset of human SR proteins predicted that E4þ74T/C may create a putative binding site for SRp40 (TTCCTC 74 G). In contrast, E4þ89C/T and E4þ94A/G may reduce the ASF/SF2 interaction and E4þ106G/A may impair SRp40 binding (arrows in Supplementary Material, Fig. S3 ). In cotransfection experiments with plasmids expressing the two SR proteins, both the wild-type and mutated clones showed an increase of intron 3 retention, but exon inclusion levels of mutated clones were similar to the wild-type minigenes (Fig. 6A) . Examination of a series of constructs mutated in the flanking sequence to maximize and minimize SRp40 matrix scores revealed considerable alterations of exon inclusion, indicative of the presence of strong ESE/ESSs, but there was no significant correlation between the matrix scores and exon inclusion (P ¼ 0.2, Fig. 6B) .
Interestingly, an ESE derived by the relative enhancer and silencer classification by unanimous enrichment (RESCUE) and termed 5D (8) was present in minigenes that showed high exon inclusion, but was absent in constructs with high 
2). (C) Influence of mutations in the 5D consensus (8) on exon inclusion (EI) in cells co-transfected with SRp20. The amount of SRp20 is in micrograms. Pictogram of ESE 5D is reproduced with permission from Science (8).
D4.
Mutations in the conserved 5D positions (nucleotides 66 -71) to nucleotides that were rare or absent in the 5D consensus significantly increased D4. The highest increase was observed for mutations of the last position (E4þ71C), which is invariant in this hexamer. In contrast, mutation 69T!G, which improves the match to 5D, lowered D4 (Fig. 6C) . As with other SR proteins (Fig. 5B) , cotransfection of mutated constructs with SRp20, which may bind 5D (8, 35, 36) , increased intron 3 retention (Fig. 6C) ; however, the SRp20-induced increase of D4 was observed for each 5D mutation.
DQB1 exon 4 skipping is increased at subphysiological temperatures
The spliceosomes assembled on different splice sites are not identical and physiological conditions may therefore differentially affect the splicing pattern of various messages. As temperature has ambivalent effects on splicing efficiency and exon inclusion (37) and BPS mutations are often associated with temperature-sensitive phenotypes in lower organisms (38), we measured D4 using real-time PCR in homozygous cell lines maintained at various temperatures prior to RNA extraction. Cells kept at 308C had the highest D4 expression relative to natural transcripts (Fig. 7A) . The D4 levels in cells maintained at 58C were similar to those observed for physiological temperatures, whereas cells kept at 208C had intermediate levels. Cell lines exhibiting the highest D4 at 378C had the peak D4 levels also at non-physiological temperatures, indicating that the differential exon skipping is maintained under stress conditions. Resuscitation of cells kept at lower temperatures for additional 24 h at 378C prior to RNA extraction normalized D4 levels (data not shown). Exon skipping was also significantly increased for transiently expressed haplotypespecific minigenes in cells maintained at 308C (Fig. 7B) . Thus, subphysiological temperatures (20 and 308C) enhanced both the endogenous and exogenous D4 expression across the cell lines.
DISCUSSION
We have shown the first examples of naturally occurring BPS haplotypes [DQB1 IVS3-26(A/G), -24(A/C/T)] that influence gene expression, providing the clearest illustration to date of haplotype control of AS. Because sDQb are present in culture supernatants of D4-positive, but not D4-negative cell lines (11), we propose that their haplotype-specific secretion is largely determined by IVS3 PPT and BPS variants through differential recognition of BPS by the KH-QUA2 domain of SF1. Our negative U2 snRNA complementation data (Fig. 4D ) appear to suggest that altered U2 snRNA -BPS base-pairing, which is obligatory in yeast with virtually invariant BPS, may not necessarily modify splicing of some human introns. This notion seems to be supported by a similar observation in human b-globin (24) and by several examples of 'U1 snRNA-independent' pre-mRNA substrates (39 -44) . In addition, if U2 snRNA -BPS interactions substantially contributed to altered splicing caused by phenotypeassociated BPS point mutations (Table 1) , one would expect to see a more uniform distribution of these changes across hBPS. Interestingly, the two positions (BP and BP-2) have been shown to be the most effective in reducing SF1 -BPS interaction (20, 25) . However, without a positive control for the U2 snRNA complementation, we could not rule out inefficient entry of transient U2 snRNA into U2 snRNPs, although RNA preparations were not enriched for snRNPs in previous studies (23, 24) . Moreover, we could not completely exclude cryptic BP usage in some constructs, including those with PPT SNPs, which may alter interaction of the 65 kDa subunit of U2 auxiliary factor ( U2AF 65 ) with the pre-mRNA and cooperative interaction between SF1 and U2AF 65 that facilitates BPS recognition (45, 46) . However, our BP mapping showed only a single inverse PCR product, a minigene with deleted BPS completely repressed splicing (Fig. 2B) and constructs with mutated BP-22A showed differential exon inclusion (Fig. 5E) , consistent with differential recognition of these BPS substitutions in vitro (27) . Finally, it is also possible that additional BPS-interacting factors, including SR proteins (47 -49) , might play a role in AS of DQB1 and in splicing defects caused by human BPS substitutions (Table 1) .
Membrane proteins are commonly regulated by mechanisms that release their soluble forms from its membrane anchorage (50) . Transmembrane domains of a large number of human and mouse proteins are removed by AS more frequently than expected and often in a tissue-specific manner (51, 52) , suggesting that these events are biologically significant. Membrane domains interact during the assembly of class II heterodimers (53) , influence the organization of endosomal compartments (54) , facilitate DM colocalization and regulate peptide exchange (55) . Although D4 are productive 
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transcripts (11) that may modulate immune responses (13, 14) and bind similar peptides as membrane-bound molecules (56), physiological significance of sDQ and their putative role in susceptibility to autoimmune disease have been obscure. Interestingly, the highest concentration of sHLA class II molecules has been observed in individuals carrying DR3 and DR4 alleles (15) , which are in linkage disequilibrium with the D4-producing DQB1 Ã 0302 and Ã 0401 (Figs 1A and 2A ). In addition, higher levels of sHLA class I molecules were found for HLA-A24 (12), which is linked to DQB1 Ã 0302 and Ã 0401. Future studies should therefore confirm whether the high D4 production is indeed reflected in increased levels of sDQb in body fluids.
Excessive amounts of D4 observed for some alleles (Fig. 7 ) provoke the hypothesis that the observed temperature-induced mRNA alterations could influence surface expression of DQ heterodimers, interactions of the peptide -MHC complexes with T-cell receptor (TCR) and, ultimately, the course of (or susceptibility to) autoimmune diseases. Most notably, joint pain in patients with rheumatoid arthritis (RA), which is associated with D4-producing DQB1 Ã 030x and Ã 040x alleles, has long been linked to low temperatures (57) . It can also be speculated that a well-known latitude gradient in the population prevalence of autoimmune disorders, sometimes attributed to pathogen distribution, ultraviolet radiation or other environmental or genetic effects, may be influenced by the temperature gradient. Since temperature-dependency of RA and other autoimmune disorders, such as systemic lupus, Behcet disease and ankylosing spondylitis (58), may also result from altered temperature-induced association and dissociation rates of peptide -MHC interactions with TCR (59), it will be interesting to examine these possibilities in future studies.
Although subphysiological temperatures enhanced exon 4 skipping of each allele (Fig. 7) , they may also elicit exon inclusion (60) or inhibit utilization of the cryptic splice site of other substrates (37) . In addition, heat shock has been shown to activate an alternative 5 0 splice site (61) and mutation of the last exon nucleotide produced an aberrant transcript not detectable at 318C, which gradually increased up to 398C (62) . Our results thus further underline the importance of fast processing of clinical samples intended for RNA analysis and temperature control during their transport and storage to minimize the number of incorrectly spliced transcripts and to avoid false positive reports of gene deletions, AS or haplotypespecific mRNA expression.
Alterations of exon inclusion induced by the majority of exonic SNPs and mutations in putative binding sites for splicing regulatory factors support a high abundance of sequences that influence pre-mRNA splicing. Interestingly, the range of exon inclusion levels produced by mutations in natural variants was smaller than for those introduced in putative splicing regulatory regions identified by RESCUE-ESE or SELEX approaches ( Figs 2C and 6B) . Alterations of exon inclusion following mutations in exonic SNPs were also less variable than in previous studies employing random mutations in coding regions (63, 64) . For example, 13 of 26 CFTR exon 9 mutations lowered exon inclusion under 15% (range 8 -98%) (64) , whereas none of our constructs mutated in exonic SNPs reduced natural transcripts below this level (range 18-76%, Fig. 2C ). This suggests that mutations in the coding region that reduce exon inclusion below an exonor gene-specific threshold are subject to significant selection at the level of pre-mRNA splicing.
Three of eight tested exonic SNPs (þ42, þ98 and þ106) were located in putative RESCUE-ESE-derived hexamers (8) . Mutations in two of them (þ106G and þ98C), which were close to the 5 0 splice site and encoded non-conservative amino acid substitutions, were predicted to remove enhancers, but they significantly reduced D4 (Fig. 2C) . E4þ42A, which was expected to retain ESE 5A/3G (8), had the opposite effect, indicating that the predictive value of putative ESEs to activate splicing is very limited without considering other interactions. In contrast, mutations in ESE 5D located in the middle part of the exon generated predicted exon inclusion levels, including the 68C!A transversion (Fig. 6C) , which corresponds to the mutation that had caused exon-skipping in a heterologous context (8) . In addition, 5D is likely to contribute to exon definition across species since the AUCUUC consensus is invariant in the mouse (GenBank accession nos K00008, K00111, M60562 and K00116), rat (M15356), pig (AY459305), cow (AY212029), sheep (Z27401), goat (AY464653), cat (AY152833), dog (Y07947) and possum (AY271265).
SR proteins typically promote exon inclusion through binding to exonic ESEs, but they may also repress splicing in vitro and in vivo ( Fig. 5; 65-70) . Similarly, PTB has been regarded as a general repressor of splicing (71), but overexpressed PTB can also promote exon inclusion (Fig. 5 ) (72, 73) . The observed opposite effects of hnRNPs and SR proteins on splicing of intron 3 and at least some of the previous, seemingly contradictory, results can be reconciled by antagonistic effects of these factors on splice site selection. Although exceptions have been noted (74) , ASF/SF2 and other SR proteins generally activate proximal splicing, whereas distal splicing is promoted by hnRNP A1 (65, 66, (75) (76) (77) (78) . DQB1 intron 3 is very weak, with the 5 0 splice sites of exon 3 and exon 4 effectively competing for splicing to exon 6. Therefore, the SR-induced intron 3 retention can be explained by a repression of the distal 5 0 splice site (i.e. 5 0 splice site of exon 3) and/or promotion of the proximal 5 0 splice site (i.e. 5 0 splice site of exon 4). Similarly, hnRNP-mediated decrease of intron 3-containing transcripts would result from a repression of the proximal splice site and/or promotion of distal splicing. Some factors did not alter isoform ratios (Fig. 5B ), but we could not exclude poor transient expression over high endogenous levels, as we did not have antibodies against hnRNP A1, hSlu7 and CELF proteins. However, the negative result with hnRNP A1 (Fig. 5B ) resembles a previous observation (79) and may reflect substrate-specific requirements. Despite this drawback, examination of a sizeable panel of hnRNPs and SR proteins, which colocalize in discrete regions of the nucleus (80, 81) , highlights the opposite effects of the two protein families on the selection of competing splice sites. It also suggests that the network of antagonistic interactions that balance splice site selection may be more extensive and that future studies may substantially add to currently known examples (65,66,75 -78,82 -85) . In addition, the novel multiallelic splicing reporter system described here will be useful to study interactions across the highly polymorphic splice (40, 41) . A prominent decrease of D4 observed for IVS3-6C!T mutations (Fig. 2B and D) can be explained by improved interactions of PPT with RRM1 of U2AF 65 or competition with other RNA binding proteins that preferentially recognize polyuridine-rich sequences (86, 87) . The pentauridine stretch characteristic of the Ã 05 lineage ( Fig. 2A ) was sufficient to maintain high exon inclusion in the cell line TEM despite weakened BPS of the DQB1 Ã 050301 allele ( Figs 1A and 2A) . Although uridines are generally the preferred pyrimidine in PPT (88, 89) , IVS-6U!C substitutions may (Fig. 2B) or may not (90) affect exon inclusion. Differential outcome of T/C substitutions in identical PPT positions relative to the 3 0 AG could be due to intron-specific binding registers of U2AF 65 (87) and/or the presence (90) or absence ( Fig. 2A) of purines in the vicinity of the 3 0 splice site that weaken PPT recognition. Because RRM1 of U2AF 65 does not crosslink to a unique set of residues at the 3 0 end of PPT (87), prediction of splicing phenotypes caused by point mutations in this region may be more problematic than those in hBPS.
MATERIALS AND METHODS
Multi-allelic splicing reporter system A 2.2 kb region containing exons 3-6 was amplified using primers A and F (Fig. 1B) with the Expand Long Template PCR System (Roche, USA) and DNA from cell lines homozygous at DQB1 (Figs 1A and 2A) . Primers are shown in Supplementary Material, Table S2 . Homozygosity and allelespecificity of template DNA was confirmed with a panel of HLA microsatellites and sequence-based typing of DQB1 and DRB1 as described (91) . Gel-purified DNA was cloned into pCR3.1 (Invitrogen, USA). Mutated minigene constructs were prepared by overlap-extension PCR and validated by sequencing as described (92) .
Sequence variability of DQB1 introns
Introns 3-5 of 10 DQB1 alleles were sequenced directly using amplicons obtained from homozygous DNA with PCR primers A-S1, A-F or G-F. Sequencing primers S1 -S7 are schematically shown in Figure 1B . The nucleotide diversity or the average number of nucleotide differences per site (P (i ) ) (93) was computed using DNA SP software (version 4) (94) with pairwise removal of the alignment gaps (Fig. 1D) . The window and step sizes were 30 and 2 nucleotides, respectively.
Expression plasmids and antibodies
Plasmids expressing ROD1 ( Table S2 . pET-15b-hnRNP H obtained from D. Black was subloned into Xho I and BamHI sites of pCR3.1. Mutated ASF/SF2 constructs were obtained from J. Caceres. In addition to previously described construct (24) , U2 snRNA was cloned into pCR3.1 and pGEM using primers U2-F/R. All clones were validated by nucleotide sequencing before transfection. The expression of a subset of proteins was confirmed by Western blotting with whole-cell lysates using antibodies against hnRNP I, H, F and K generously provided by D. Black, G. Dreyfus, T. Tamura and C. Smith.
Homozygous cell lines
Cell lines or DNA samples carrying the indicated alleles (Figs 1A and 2A) were purchased from the European Cell Culture Collection (Salisbury, UK) or were a gift from S. Marsh and N. Mayor, Anthony Nolan Research Institute. Cell lines were grown in RPMI1640 with 1% glutamine (v/v) supplemented with 10% fetal calf serum. DNA was extracted as described (92) . Total RNA was isolated using RNeasy Mini Kit (Qiagen, Germany). First-strand cDNA was reverse transcribed using oligo(dT) 15 
Transfections
HeLa and 293T cells were grown under standard conditions in RPMI1640 supplemented with 10% (v/v) fetal calf serum (Gibco BRL, USA). Transient transfections were performed in 6-or 12-well plates using FuGENE 6 (Roche) according to manufacturer's recommendations. Cells were harvested with trypsin 48 h post-transfection.
Detection of DQB1 isoforms
Total RNA was isolated using RNeasy Mini Kit (Qiagen) or Tri-reagent (Sigma, USA) and treated with DNaseI (Ambion, USA). First-strand cDNA was reverse transcribed using oligo(dT) 15 primers and Moloney murine virus reverse transcriptase (M-MLV H 2 ; Promega) according to manufacturer's recommendations. Exon inclusion levels were measured on ethidium bromide-stained gels with FluorImager 595 using FluorQuant and Phoretix software (Nonlinear Dynamics Inc., USA). DNA bands were extracted from the gel and sequenced to confirm the identity of each fragment. The number of PCR cycles was 28 or lower to maintain approximately linear relationship between the RNA input and signal. Design of real-time RT -PCR with primers/probes T26 -T45 is shown in Supplementary Material, Figure S1 . Standard curves were constructed using serial dilutions of DNA extracted from plasmids containing allele-specific inserts cloned using amplicons that were derived from lymphoblastoid cell lines homozygous at DQB1 (Figs 1A and 2A) . Detection of BPS haplotypes and U2 snRNA expression A 153 nucleotide fragment containing the BPS-interacting region of U2 snRNA was amplified using single-strand confirmation primers (SSCP)-F/R (Supplementary Material, Table S2 ). SSCP assays were carried out as described (92) . ARMS -PCR (19) for the population screening of BPS associated with the lowest exon inclusion (Fig. 3C and D) was with DNA samples ascertained as described previously (100). Ethics approval was granted by a local committee. The specificity of ARMS -PCR was tested using DNAs isolated from plasmids mutated in BPS (Fig. 3C) .
RNA secondary structure predictions
The lowest free energy structures were predicted using enhanced free energy minimization algorithms and plotted ( Fig. 5D ) with the RNA Structure (version 3.7) (101).
Gel mobility shift assays
Gel shift experiments were carried out as described (21) . Ten microlitre reactions contained 32 mM Tris-HCl (pH 8.0), 160 mM NaCl, 8 mM imidazole, 4 mM b-mercaptoethanol, 2.5 mg tRNA, 0.01 pmol of 5 0 [ 32 P]-ATP-labelled oligoribonucleotides (Biospring, Germany).
Branchpoint mapping
A two-exon fragment amplified with primers A and D (Fig. 1B) using homozygous DNA was cloned into pGEM-T Easy (Promega, USA), linearized with Sal I and in vitro transcribed using MAXIscript and m 7 G(5 0 )ppp(5 0 )G cap analog (Ambion) in the presence and absence of [a-
32 P]-UTP. PremRNA was incubated with 30% of HeLa nuclear extracts (4C, Belgium), ATP (0.5 mM), creatine phosphate (20 mM), MgCl 2 (2 mM), 20 U of RNasin (Promega), PVA (2.6%) and 30% of buffer E (5% glycerol, 0.5 mM dithiothreitol, 0.2 mM EDTA, 100 mM KCl and 20 mM HEPES, pH 7.8) in a 25 ml volume at 308C for 3 h. Reactions were stopped by adding proteinase K at a final concentration of 200 ng/ml. RNA was extracted with phenol, and precipitated with ethanol. Isotopically labeled RNA was loaded onto 5% PAGE (Fig. 3A) . Non-labeled RNA was reverse-transcribed with M-MLV (H 2 ) RT (Promega, USA) and primer BP-RT. Two microlitres of the first-strand cDNA were used as a template for PCR with primers BP-F/BP-R at an annealing temperature of 568C. Amplification primers were designed using the Oligo programme (version 6.63) according to an expected cDNA template. A single PCR product of 113 nucleotides was gelpurified and sequenced as described (92) .
